VERZONI, ELENA
 Distribuzione geografica
Continente #
EU - Europa 1.322
NA - Nord America 989
AS - Asia 291
OC - Oceania 9
SA - Sud America 8
AF - Africa 2
Totale 2.621
Nazione #
US - Stati Uniti d'America 978
DE - Germania 529
GB - Regno Unito 365
CN - Cina 161
SE - Svezia 150
IT - Italia 127
IE - Irlanda 45
FI - Finlandia 35
FR - Francia 32
HK - Hong Kong 30
IN - India 27
JP - Giappone 22
KR - Corea 22
SG - Singapore 14
AU - Australia 9
CA - Canada 8
UA - Ucraina 6
BE - Belgio 5
NL - Olanda 5
BR - Brasile 4
AT - Austria 3
CH - Svizzera 3
CO - Colombia 3
ES - Italia 3
MX - Messico 3
RU - Federazione Russa 3
TR - Turchia 3
TW - Taiwan 3
GR - Grecia 2
MY - Malesia 2
VN - Vietnam 2
AR - Argentina 1
BG - Bulgaria 1
DK - Danimarca 1
EE - Estonia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
LI - Liechtenstein 1
MD - Moldavia 1
ME - Montenegro 1
NO - Norvegia 1
NP - Nepal 1
PK - Pakistan 1
PL - Polonia 1
SI - Slovenia 1
TN - Tunisia 1
Totale 2.621
Città #
Frankfurt am Main 472
Southend 332
Chandler 195
Milan 84
Fairfield 82
Ashburn 78
Seattle 68
Wilmington 68
Princeton 60
Dublin 45
Houston 36
Woodbridge 34
Munich 33
Cambridge 31
Nanjing 30
Hong Kong 29
New York 29
Beijing 24
Dearborn 24
Bengaluru 18
Ann Arbor 13
Des Moines 13
Phoenix 13
Redwood City 12
Shanghai 12
Eitensheim 11
Helsinki 11
London 11
Shenyang 8
Hangzhou 7
Hebei 7
Tokyo 7
Changsha 6
Jinan 6
Nanchang 6
Silver Spring 6
Toronto 6
Zhengzhou 6
Chicago 5
Guangzhou 5
Jiaxing 5
San Diego 5
Brussels 4
Fremont 4
Los Angeles 4
Norwalk 4
Tianjin 4
Boardman 3
Bogotá 3
Grafing 3
San Francisco 3
Seoul 3
São Paulo 3
Vienna 3
Amsterdam 2
Athens 2
Berlin 2
Fuzhou 2
Hanoi 2
Hefei 2
Herne 2
Kuala Lumpur 2
Matsumicho 2
Medford 2
Mexico City 2
Petoskey 2
Pioltello 2
Rho 2
Rome 2
San Jose 2
Sandwich 2
Singapore 2
Taiyuan 2
Wuhan 2
Zurich 2
Acton 1
Akita 1
Amman 1
Ankara 1
Arcadia 1
Arnhem 1
Barcelona 1
Boisbriand 1
Brooklyn 1
Burlingame 1
Burwood 1
Canberra 1
Central 1
Charlotte 1
Chennai 1
Chisinau 1
Cincinnati 1
Cleveland 1
Concesio 1
Davis 1
Duncan 1
Edinburgh 1
Farmington 1
Foggia 1
Fujisawa 1
Totale 2.061
Nome #
Cabozantinib in the treatment of advanced renal cell carcinoma : Design, development, and potential place in the therapy 183
Targeted treatments in advanced renal cell carcinoma : focus on Axitinib 155
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma? 142
Clinical impact of Pancreatic metastases from renal cell carcinoma : A multicenter retrospective analysis 137
Butterfly and renal cell cancer : Out of chaos comes order 136
Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors 125
Treatment of collecting duct carcinoma : current status and future perspectives 114
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors : implications for clinical practice, trial design, and molecular interrogation 109
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma 107
Rationale and protocol of RESORT, a randomized, open-label, multicenter phase II study to evaluate the efficacy of sorafenib in patients with advanced renal cell carcinoma after radical resection of the metastases 101
Time from nephrectomy as a prognostic factor in metastatic renal cell carcinoma patients receiving targeted therapies : overall results from a large cohort of patients 100
From biology to clinical experience : evolution in the knowledge of neuroendocrine tumours 96
Safety of abiraterone acetate in castration-resistant prostate cancer patients with concomitant cardiovascular risk factors 89
Safety profile and treatment response of everolimus in different solid tumors : an observational study 89
First line treatment of metastatic renal cell carcinoma : two standards with different toxicity profile 80
Patient approach in advanced/metastatic renal cell carcinoma : focus on the elderly population and treatment-related toxicity 80
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma : a systematic review and meta-analysis of literature data 80
Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer : a systematic review and meta-analysis 79
Immunotherapy advances in uro-genital malignancies 79
Study design and clinical evidence in mRCC : can we save axitinib as a first-line therapy? 76
Treatment of elderly patients with metastatic renal cell carcinoma 73
Sequential Tyrosine Kinase Inhibitors (TKIs) in metastatic renal cell carcinoma : results from a large cohort of patients 71
Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib 70
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents 66
Rationale and protocol of SOAP : A phase II study to evaluate the efficacy of Sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma 64
Management of advanced genitourinary tumors 59
Biomarker-driven immunotherapy for precision medicine in prostate cancer 59
Prognostic role of pancreatic metastases from renal cell carcinoma : Results from an Italian center 54
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) 54
Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients 50
Targeted therapies and survival: What we can learn from studies in advanced renal cell carcinoma 35
Totale 2.812
Categoria #
all - tutte 6.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.707


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201968 0 0 0 0 0 0 0 0 0 20 22 26
2019/2020303 46 16 11 31 17 34 32 24 38 30 11 13
2020/2021196 19 16 10 10 25 24 9 11 39 11 8 14
2021/2022276 15 12 8 7 9 12 11 22 14 29 12 125
2022/2023527 52 93 61 65 33 84 17 25 63 6 26 2
2023/2024678 5 23 29 6 95 9 160 161 67 123 0 0
Totale 2.812